Mohamed F Doheim: Bridging Therapy Improves Outcomes in M2 MCA Occlusions
Mohamed F Doheim, Faculty Instructor (Research) at NIH StrokeNet, shared a post on X:
”Proud to share our new study in Stroke AHA/ASA. In patients with M2 MCA occlusions, bridging therapy (IVT+EVT) was associated with better 90-day functional outcomes compared to EVT alone, with no major safety concerns.”
Read the full article here.
Title: Direct Endovascular Versus Bridging Therapy in M2 Segment Occlusion of Middle Cerebral Artery: A MR CLEAN Registry Study
Authors: Mohamed F. Doheim, Robrecht R.M.M. Knapen, Julie Staals, Wouter J. Schonewille, Diederik W.J. Dippel, Adriaan C.G.M. van Es, Hester F. Lingsma, Christiaan van der Leij, Charles B. Majoie, Raul G. Nogueira, Robert J. van Oostenbrugge, Wim H. van Zwam
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp